Two Bristol Myers Squibb (BMS) researchers at work. BMS will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology and immunology, the companies said today, through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results